The number of people with susceptibility test result for rifampicin in Finland
Finland: The number of people with susceptibility test result for rifampicin was 87 in 2021. ▼ Falling
Latest (2021)
87
Change on year
down 13.0%
World rank
111th
of 155 countries
All-time high
134
in 2017
All-time low
87
in 2021
Years of data
5
2017–2021
The number of people with susceptibility test result for rifampicin in Finland, 2017–2021
Source: World Health Organization, Global Health Observatory.
Analysis
In 2021, the number of people with susceptibility test result for rifampicin in Finland stood at 87. That is the lowest value across all 5 years on record.
That represents a change of down 13.0% on the previous year and down 35.1% over five years.
That places Finland 111th out of 155 countries with data for 2021, putting it in the middle of the range.
The number of people with susceptibility test result for rifampicin in Finland, year by year
| Year | Value | Change |
|---|---|---|
| 2017 | 134 | — |
| 2018 | 127 | -5.2% |
| 2019 | 121 | -4.7% |
| 2020 | 100 | -17.4% |
| 2021 | 87 | -13.0% |
Finland compared with similar countries
- Finland's 87 is below the median for high income countries, which is 142, 61% of the median. (61 countries reporting)
- Finland's 87 is below the median for Europe & Central Asia, which is 229.5, 38% of the median. (44 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2010s | 127.33 | 121 | 134 | 3 |
| 2020s | 93.5 | 87 | 100 | 2 |
Countries ranked near Finland
More health data for Finland
- Un projection of annual infant deaths, annual growth rate 0 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate -0.4544 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,271 deaths per 1,000 people (2090)
- Number of infants who die before age 1 11 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 0 (2025)
- Population ages 00-04, female, annual growth rate -0.4631 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0202 units per person (2025)
- Population ages 00-04, male, annual growth rate -0.1502 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is the number of people with susceptibility test result for rifampicin in Finland?
- The number of people with susceptibility test result for rifampicin in Finland was 87 in 2021, according to World Health Organization, Global Health Observatory.
- What is the highest the number of people with susceptibility test result for rifampicin recorded in Finland?
- The highest recorded value was 134 in 2017.
- What is the lowest the number of people with susceptibility test result for rifampicin recorded in Finland?
- The lowest recorded value was 87 in 2021.
- How does Finland rank for the number of people with susceptibility test result for rifampicin?
- Finland ranks 111th out of 155 countries with data for 2021.
- Where does this Finland data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 5 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).